08.12.2012 Views

MATELAN Research - ISRA VISION AG

MATELAN Research - ISRA VISION AG

MATELAN Research - ISRA VISION AG

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>ISRA</strong> <strong>VISION</strong> In-Depth Report<br />

VALUATION<br />

DCF and peer group<br />

valuation<br />

Three stage DCF model<br />

Conservative long-term<br />

assumptions for growth,<br />

margins …<br />

… and WACC<br />

calculation<br />

Fair value of EUR23.6<br />

- 5 -<br />

For valuation purposes, we use a detailed DCF model and a peer group<br />

comparison based on the most important valuation multiples. While the DCF<br />

model is our main valuation tool, which allows for an in-depth discussion of<br />

<strong>ISRA</strong>’s most important value drivers, the peer group comparison is used as a<br />

validity check for our results.<br />

Our DCF model calculates <strong>ISRA</strong>’s fair value by discounting the company’s<br />

future free cash flows. In the first phase, we derive the free cash flows from<br />

our detailed financial modelling, which is discussed in the financial section of<br />

this report. The cash flows are then estimated via linearization of all<br />

important value drivers to a normalized value. From the latter, the terminal<br />

value is calculated.<br />

As the terminal value assumptions in particular have a large impact on the<br />

valuation, we have kept them conservative: We have, for example, set the<br />

growth rate of total output to 1.5%, which is merely reflecting inflation. We<br />

thus assume no real growth in <strong>ISRA</strong>’s total output in the terminal value. To<br />

underline this, we have equated the depreciation rate with the rate of<br />

investment, meaning that the company is only replacing its capital invested in<br />

the business and not expanding it. In addition, we have set the EBITDA<br />

margin slightly below its value in the last explicitly estimated period (i.e.<br />

2014/15). Moreover, we have not assumed any further improvements in<br />

<strong>ISRA</strong>’s working capital in the terminal value.<br />

All free cash-flows are discounted with the company’s weighted average cost<br />

of capital. This is based on the current forward rates of German government<br />

bonds as risk-free rates. To determine the cost of debt, we add the credit<br />

spread and adjust the tax shield. On the equity side, we add a market risk<br />

premium, which is weighted with a beta factor. In order to reflect current<br />

uncertainties with regard to the economic development in 2012, which is<br />

documented in the recent sell-off on equity markets, we have raised the<br />

market risk premium for small caps by 1pp to now 7%. The beta factor is<br />

derived fundamentally, taking into account the company’s risk profile as<br />

summarized below. In the case of <strong>ISRA</strong>, we see a higher risk compared to the<br />

market in all risk categories, which results in a final beta factor of 1.2.<br />

Weighting the cost of equity and debt with the market values of the<br />

company’s equity and debt, we come to WACCs between 7.5% and 11.4%<br />

for the years under review.<br />

All assumptions of our valuation are detailed in the table below and result in a<br />

fair value of EUR23.6, which provides the share with an upside of roughly<br />

35% to the current price. It should be highlighted that under the same set of<br />

assumptions our fair value would come to EUR26.5 if we had not raised the<br />

market risk premium. This represents an additional upside if equity markets<br />

start to normalise and <strong>ISRA</strong> delivers on the expected earnings streams.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!